CTI BioPharma
CTIC
#5622
Rank
HK$9.33 B
Marketcap
HK$70.76
Share price
0.00%
Change (1 day)
30.87%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : HK$0.87 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are HK$0.87 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31HK$0.98 B74.2%
2021-12-31HK$0.56 B25.1%
2020-12-31HK$0.45 B25.26%
2019-12-31HK$0.36 B-48.76%
2018-12-31HK$0.70 B64.05%
2017-12-31HK$0.42 B-13.38%
2016-12-31HK$0.49 B-55.74%
2015-12-31HK$1.11 B56.28%
2014-12-31HK$0.71 B-1.51%
2013-12-31HK$0.72 B27.2%
2012-12-31HK$0.57 B18.2%
2011-12-31HK$0.48 B15.91%
2010-12-31HK$0.41 B-22.71%
2009-12-31HK$0.53 B8.7%
2008-12-31HK$0.49 B-13.39%
2007-12-31HK$0.57 B-27.62%
2006-12-31HK$0.79 B-34.29%
2005-12-31HK$1.20 B-16.17%
2004-12-31HK$1.43 B26.96%
2003-12-31HK$1.13 B-22.26%
2002-12-31HK$1.45 B-38.5%
2001-12-31HK$2.36 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Amgen
AMGN
HK$701.71 B 80,188.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$754.24 B 86,198.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
HK$49.27 B 5,538.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
HK$163.99 B 18,664.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$894.72 B 102,271.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$310.26 B 35,399.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
HK$835.20 B 95,461.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland